MiR-21 overexpression improves osteoporosis by targeting RECK

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Osteoporosis is a metabolic bone disorder with unclear microRNA involvement.
• MicroRNA-21 (miR-21) is implicated in bone formation, but its specific role in osteoporosis requires elucidation.

Purpose of the Study:

• To investigate the role of miR-21 in osteoporosis.
• To identify the molecular mechanisms underlying miR-21's function in bone metabolism.
• To explore RECK as a potential therapeutic target for osteoporosis.

Main Methods:

• Utilized mesenchymal stem cells (MSCs) treated with TNF-α and miR-21 mimics/inhibitors.
• Performed luciferase reporter gene assays to confirm miR-21 binding to RECK.
• Established an in vivo osteoporosis model using ovariectomized (OVX) mice.
• Administered lentiviral RECK shRNA to OVX mice for therapeutic intervention.

Main Results:

• TNF-α inhibited miR-21 expression, inducing MSC apoptosis and impairing proliferation/differentiation; miR-21 mimics reversed these effects.
• miR-21 directly targeted and inhibited RECK expression, which was validated by luciferase assays.
• RECK siRNA mimicked miR-21 mimics' effects, reversing TNF-α-induced changes in MSCs.
• In OVX mice, miR-21 was downregulated, and RECK was upregulated.
• RECK shRNA treatment in OVX mice decreased osteocalcin and alkaline phosphatase activity but improved bone mineral density.

Conclusions:

• miR-21 modulates osteoporosis by targeting RECK, highlighting its critical role in bone metabolism.
• RECK emerges as a potential therapeutic target for managing osteoporosis.
• Further research into the miR-21/RECK axis could lead to novel osteoporosis treatments.